In a pandemic with scarce resources, governments, medical institutions, and healthcare providers have had to make decisions and/or policies about allocating potentially lifesaving therapies among the many outpatients who might benefit from them.
all want this nightmare to be over. We want to be rid of masks and to be able to enjoy our social and public life again. We are tired of waiting to feel safe enough to share a show, a meal, or a pint with friends.
If we with CLL/SLL are waiting for 100% security against COVID-19, our wait may never end.
Indeed, staying at home and not venturing out or inviting anyone over will protect us, but at what cost? What family milestones or everyday joys will we miss? What adventures and new and old
By Susan J. Leclair, PhD, CLS (NCA) I know it is a common belief that statistics and lies are synonymous, mostly I think because statistics seems so foreign to most people. Statistics tries to answer in numbers only a few questions, but uses several different methods to try to
Dr. Rick Furman of Weill-Cornell answers your questions in our ASK THE DOCTOR feature in our quarterly newsletters, responds to many more questions in the CLLSLL.io group, (an active forum for CLL patients and caregivers worth checking out), and has done pivotal research on new therapies that have redefined
This is not an article about CLL, but in a way it is. The link between heart disease and cancer is becoming stronger. See http://www.sciencedirect.com/science/article/pii/S0092867410000607 Chronic lymphocytic leukemia (CLL) is likely no exception. There is recent evidence that even precancerous blood clones are associated with atherosclerotic cardiovascular disease in